Related content

Substantia nigra hyperechogenicity in healthy controls: a [¹⁸Fluoro] Dopa-PET follow-up study

By Schroeder Ute   Behnke Stefanie   Buchholz Hans-Georg   Fassbender Klaus   Schreckenberger Matthias   Berg Daniela  

Journal of Neurology, Vol. 260, Iss. 7, 2013-07 ,pp. : 1907-1911

Springer Publishing Company

Access to resources Recommend Favorite

Screening for mutations of the IRP2 gene in Parkinson’s disease patients with hyperechogenicity of the substantia nigra

By Deplazes J.   Schöbel K.   Hochstrasser H.   Bauer P.   Walter U.   Behnke S.   Spiegel J.   Becker G.   Riess O.   Berg D.  

Journal of Neural Transmission, Vol. 111, Iss. 4, 2004-04 ,pp. : 515-521

Springer Publishing Company

Access to resources Recommend Favorite

Cross-sectional study discloses a positive family history for Parkinson's disease and male gender as epidemiological risk factors for substantia nigra hyperechogenicity

By Schweitzer K. J.   Behnke S.   Liepelt I.   Wolf B.   Grosser C.   Godau J.   Gaenslen A.   Bruessel T.   Wendt A.   Abel F.   Müller A.   Gasser T.   Berg D.  

Journal of Neural Transmission, Vol. 114, Iss. 9, 2007-09 ,pp. : 1167-1171

Springer Publishing Company

Access to resources Recommend Favorite

The substantia nigra of the human brain

By Damier P.   Hirsch E. C.   Agid Y.  

Brain, Vol. 122, Iss. 8, 1999-08 ,pp. : 1421-1436

Oxford University Press

Access to resources Recommend Favorite

The substantia nigra of the human brain

By Damier P.   Hirsch E. C.   Agid Y.  

Brain, Vol. 122, Iss. 8, 1999-08 ,pp. : 1437-1448

Oxford University Press

Access to resources Recommend Favorite